Koninklijke Philips N.V. (NYSE:PHG) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Koninklijke Philips N.V. (NYSE:PHGGet Free Report) have received an average recommendation of “Moderate Buy” from the five analysts that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has given a strong buy recommendation to the company.

A number of research analysts have issued reports on PHG shares. Weiss Ratings reissued a “hold (c-)” rating on shares of Koninklijke Philips in a research report on Monday. Wall Street Zen raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Finally, Royal Bank Of Canada assumed coverage on shares of Koninklijke Philips in a research note on Wednesday. They issued a “sector perform” rating for the company.

Read Our Latest Report on Koninklijke Philips

Koninklijke Philips Trading Down 1.0%

Shares of PHG stock traded down $0.27 during trading hours on Wednesday, reaching $26.26. The company’s stock had a trading volume of 199,540 shares, compared to its average volume of 906,743. The company has a current ratio of 1.32, a quick ratio of 0.86 and a debt-to-equity ratio of 0.68. Koninklijke Philips has a one year low of $21.48 and a one year high of $29.54. The stock has a market capitalization of $25.29 billion, a P/E ratio of 131.31, a P/E/G ratio of 0.71 and a beta of 0.79. The firm’s fifty day simple moving average is $27.81 and its 200 day simple moving average is $26.56.

Koninklijke Philips (NYSE:PHGGet Free Report) last announced its earnings results on Tuesday, November 4th. The technology company reported $0.37 EPS for the quarter, meeting analysts’ consensus estimates of $0.37. Koninklijke Philips had a return on equity of 12.14% and a net margin of 1.07%.The company had revenue of $5.05 billion during the quarter, compared to the consensus estimate of $4.30 billion. Equities research analysts expect that Koninklijke Philips will post 1.63 EPS for the current year.

Institutional Trading of Koninklijke Philips

Hedge funds have recently modified their holdings of the business. Johnson Financial Group Inc. bought a new position in shares of Koninklijke Philips in the third quarter worth approximately $27,000. AlphaCore Capital LLC bought a new position in Koninklijke Philips in the 2nd quarter valued at approximately $41,000. Whipplewood Advisors LLC boosted its stake in Koninklijke Philips by 39.1% during the 2nd quarter. Whipplewood Advisors LLC now owns 2,108 shares of the technology company’s stock valued at $51,000 after purchasing an additional 592 shares during the last quarter. MAI Capital Management increased its holdings in shares of Koninklijke Philips by 167.7% in the 2nd quarter. MAI Capital Management now owns 2,380 shares of the technology company’s stock worth $57,000 after purchasing an additional 1,491 shares in the last quarter. Finally, Root Financial Partners LLC purchased a new position in shares of Koninklijke Philips in the third quarter worth $83,000. Institutional investors own 13.67% of the company’s stock.

About Koninklijke Philips

(Get Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

Further Reading

Analyst Recommendations for Koninklijke Philips (NYSE:PHG)

Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.